Port Orchard, WA, United States of America

Jesse H Erasmus

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jesse H. Erasmus

Introduction

Jesse H. Erasmus is a notable inventor based in Port Orchard, WA (US). She has made significant contributions to the field of nanotechnology, particularly in the development of lipid carrier compositions for biomedical applications. Her work focuses on enhancing the delivery of biomolecules to cells, which is crucial for generating immune responses.

Latest Patents

Jesse H. Erasmus holds a patent for "Nanostructured lipid carriers and stable emulsions and uses thereof." This patent describes compositions that include a nanostructured lipid carrier (NLC) made from a mixture of liquid and solid phase lipids, cationic lipids, sorbitan esters, and hydrophilic surfactants. The compositions are designed to deliver bioactive agents effectively, facilitating vaccine, therapeutic, or diagnostic uses. The methods outlined in her patent provide innovative approaches to stimulate immune responses.

Career Highlights

Erasmus has established herself as a key figure in her field through her work at Access to Advanced Health Institute. Her research and inventions have the potential to revolutionize how biomolecules are delivered in medical applications. With one patent to her name, she continues to push the boundaries of what is possible in nanotechnology.

Collaborations

Jesse H. Erasmus has collaborated with notable colleagues, including Christopher B. Fox and Amit Praful Khandhar. These partnerships have contributed to her innovative research and the advancement of her patented technologies.

Conclusion

Jesse H. Erasmus is a pioneering inventor whose work in nanostructured lipid carriers has significant implications for medical science. Her contributions are paving the way for new methods of delivering biomolecules, which could enhance vaccine and therapeutic efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…